Documentos de Académico
Documentos de Profesional
Documentos de Cultura
8/17/12
Incretinas
8/17/12
GLP-1
8/17/12
GIP
8/17/12
A review of published, peer-reviewed medical literature (1987 to September 2008) on the extrapancreatic actions of GLP1.
8/17/12
D P P 4
GLP-1
8/17/12
Da 1 Da 3
Da 5
FarillaLetalEndocrinology2003;144:51495158.
8/17/12
En diabticos
8/17/12
8/17/12
8/17/12
DPP-4
Dipeptidyl Peptidasa 4 (CD 26)
8/17/12
Es la causante de la rpida
La inhibicin de la DPP-4 resulta en la prolongacin del efecto fisiolgico de las incretinas endgenass
Dipeptidil Peptidasa IV
8/17/12
Estrategias de tratamiento
8/17/12
SITAGLIPTINA
VILDAGLIPTINA
SAXAGLIPTINA
ALOGLIPTINA
INHIBIDORES DE LA DPP-4
8/17/12
Mecanismo de accin
8/17/12
Eficacia
8/17/12
Sitagliptina
8/17/12
Sitagliptina: Efectos
secundarios:
8/17/12
8/17/12
Diferencias
8/17/12
8/17/12
8/17/12
8/17/12
Contraindicaciones Absolutas
8/17/12
Relativas
8/17/12
Interacciones
8/17/12
Bibliografa
[1] The Word Health Organisation, Diabetes mellitus Fact sheet Number 312. Retrieed November 2008: http://www.who.int/mediacentre/facts heets/fs312/es/index.html [2] The Word Health Organisation, Diabetes mellitus Fact sheet Number 312. Retrieed November 2008: http://www.who.int/mediacentre/facts heets/fs312/es/index.html 8/17/12 [3]International Diabetes Federation,